ArticleScientific reports2026
A deep learning approach for the diagnosis and recurrence prediction of OKC.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Odontogenic Keratocyst (OKC) is a benign jaw tumor characterized by a high recurrence rate. However, its clinical diagnosis presents significant challenges due to complex pathological morphologies and inconspicuous early symptoms. In this paper, we propose an intelligent OKC diagnosis system that leverages multimodal data fusion and interpretable analysis. Specifically, we first devise a Multimodal Feature-based Diagnosis Model (MFDM), which utilizes a Spatial Feature Fusion Module (SFFM) to fuse features extracted from patients' oral pathological slides and tabular clinical parameters. Second, we formulate an Interpretable Recurrence Prediction Model (IRPM) that extracts features from patient demographics and medical history records. This model harnesses an attention mechanism to weight these features, thereby realizing a quantitative estimation of OKC recurrence risk. Furthermore, we implement an integrated information management platform that deploys both MFDM and IRPM. This platform facilitates OKC detection, risk prediction, case storage, and key data visualization, significantly facilitating the algorithm's usability. We conduct extensive comparative and ablation experiments on collected datasets. The results demonstrate that our approach achieves higher accuracy in both diagnosis and recurrence prediction compared to existing state-of-the-art models. Moreover, the visualization elucidates the rationale behind the model's decision-making process, reinforcing its interpretability and credibility for clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.